Entasis 2020-01: Efficacy of Novel Therapeutic Combinations in the Murine UTI Model with Four E. Coli Isolates

Project Details

StatusFinished
Effective start/end date1/08/2031/07/21

Funding

  • Entasis Therapeutics: $89,939.63